Antiviral Potential of Lactic Acid Bacteria and Their Bacteriocins

Probiotics and Antimicrobial Proteins - Tập 6 Số 3-4 - Trang 177-185 - 2014
Imad Al Kassaa1,2, Didier Hober3, Monzer Hamzé2, Nour‐Eddine Chihib1, Djamel Drider1
1Institut Charles Viollette - Université Lille 1, Villeneuve d’Ascq Cedex, France
2Laboratoire de Microbiologie Santé et Environnement, Rue Mitein, AZM Center of Biotechnologie, EDST-Université Libanaise at Tripoli, Tripoli, Lebanon
3CHRU Lille Laboratoire de Virologie EA3610, Université Lille 2 Faculté de Médecine, Loos-lez-Lille, France

Tóm tắt

Từ khóa


Tài liệu tham khảo

FAO/WHO (2002) Joint working group report on guidelines for the evaluation of probiotics in food. London, Ontario, Canada

Villena J, Oliveira ML, Ferreira P, Salva S, Alvarez S (2011) Lactic acid bacteria in the prevention of pneumococcal respiratory infection: future opportunities and challenges. Int Immunopharmacol 11:1633–1645

Liu SQ (2003) Practical implications of lactate and pyruvate metabolism by lactic acid bacteria in food and beverage fermentations. Int J Food Microbiol 83:115–131

Belhadj H, Harzallah D, Khennouf S, Dahamna S, Bouharati S, Baghiani A (2010) Isolation, identification and antimicrobial activity of lactic acid bacteria from Algerian honeybee collected pollen. Acta Hort (ISHS) 854:51–58

Mercenier A, Pavan S, Pot B (2003) Probiotics as biotherapeutic agents. Curr Pharm Des 9:175–191

Harzallah D, Belhadj H (2013) Lactic acid bacteria as probiotics: characteristics, selection criteria and role in immunomodulation of human GI muccosal barrier Chapter 8. Book: 198 Lactic Acid Bacteria – R & D for Food, Health and Livestock Purposes, Inteck edition

Lakshmi B, Viswanath B, Sai Gopal DV (2013) Probiotics as antiviral agents in shrimp aquaculture. J Pathog 2013:424123. doi: 10.1155/2013/424123

Seo BJ, Rather IA, Kumar VJ, Choi UH, Moon MR, Lim JH, Park YH (2012) Evaluation of Leuconostoc mesenteroides YML003 as a probiotic against low-pathogenic avian influenza (H9N2) virus in chickens. J Appl Microbiol 113:163–171

Guarner F, Schaafsma GJ (1998) Probiotics. Int J Food Microbiol 17:237–238

Botić T, Klingberg TD, Weingartl H et al (2007) A novel eukaryotic cell culture model to study antiviral activity of potential probiotic bacteria. Int J Food Microbiol 115:227–234

Wang Z, Chai W, Burwinkel M, Twardziok S, Wrede P, Palissa C, Esch B, Schmid MFG (2013) Inhibitory influence of Enterococcus faecium on the propagation of swine influenza a virus in vitro. PLoS One 8:e53043

Al Kassaa I, Hamze M, Hober D et al (2014) Identification of vaginal lactobacilli with potential probiotic properties isolated from women in North Lebanon. Microb Ecol 67:722–734

Kawashima T, Kyoko H, Akemi K, Megumi K et al (2011) Lactobacillus plantarum strain YU from fermented foods activates Th1 and protective immune responses. Int Immunopharmacol 11:2017–2024

Klebanoff SJ, Coombs RW (1991) Viricidal effect of Lactobacillus acidophilus on human immunodeficiency virus type 1: possible role in heterosexual transmission. J Exp Med 174:289–292

Conti C, Malacrino C, Mastromarino P (2009) Inhibition of herpes simplex virus type 2 by vaginal lactobacilli. J Physiol Pharmacol 6:19–26

Martin LS, McDougal JS, Loskoski SL (1985) Disinfection and inactivation of the human lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 152:400–403

Martin V, Maldonado A, Fernandez L, Rodriguez JM, Connor RI (2010) Inhibition of human immunodeficiency virus type 1 by lactic acid bacteria from human breastmilk. Breastfeed Med 5:153–158

Tuyama AC, Cheshenko N, Carlucci MJ, Li JH, Goldberg CL, Waller DP, Anderson RA, Profy AT, Klotman ME, Keller MJ, Herold BC (2006) Acidform inactivates herpes simplex virus and prevents genital herpes in a mouse model: optimal candidate for microbicide combinations. J Infect Dis 194:795–803

Mastromarino P, Cacciotti F, Masci A, Mosca L (2011) Antiviral activity of Lactobacillus brevis towards herpes simplex virus type 2: role of cell wall associated components. Anaerobe 17:334–336

Hill JA, Anderson DJ (1992) Human vaginal leukocytes and the effects of vaginal fluid lymphocyte and macrophage defense functions. Am J Obstet Gynecol 166:720–726

Ennahar S, Sashihara T, Sonomoto K, Ishizaki A (2000) Class IIa bacteriocins: biosynthesis, structure and activity. FEMS Microbiol Rev 24:85–106

Klaenhammer TR (1993) Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol Rev 12:39–86

Cotter PD, Hill C, Ross RP (2005) Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 3:777–788

Abee T (1995) Pore-forming bacteriocins of Gram-positive bacteria and self-protection mechanisms of producer organisms. FEMS Microbiol Lett 129:1–10

Abee T, Krockel L, Hill C (1995) Bacteriocins: modes of action and potentials in food preservation and control of food poisoning. Int J Food Microbiol 28:169–185

Moll GN, Konings WN, Driessen AJM (1999) Bacteriocins: mechanism of membrane insertion and pore formation. Antonie Van Leeuwenhoek 76:185–198

Drider D, Rebuffat S (2011) Prokaryotic antimicrobial peptides: from genes to applications. Springer, New York, ISBN 9781441976918

Humaira Q, Sadia S, Ahmed S, Ajaz Rasool S (2006) Coliphage hsa as a model for antiviral studies/spectrum by some indigenous bacteriocin like inhibitory substances (BLIS). Pak J Pharma Sci 19:182–187

Saeed S, Rasool RA, Ahmad S, Zaidi SZ, Rehmani S (2007) Antiviral activity of Staphylococcin 188: a purified bacteriocin like inhibitory substance isolated from Staphylococcus aureus AB188. Res J Microbiol 2:796–806

Todorov SD, Wachsman M, Tomé E, Dousset X, Destro MT, Dicks LM, Franco BD, Vaz-Velho M, Drider D (2010) Characterisation of an antiviral pediocin-like bacteriocin produced by Enterococcus faecium. Food Microbiol 27:869–879

Wachsman MB, Farias ME, Takeda E, Sesma F, De Ruiz Holgado AP, de Torres RA, Coto CE (1999) Antiviral activity of enterocin CRL against herpes virus. Int J Antimicrob Agents 12:293–299

Todorov SD, Wachsman MB, Knoetze H, Meincken M, Dicks LMT (2005) An antibacterial and antiviral peptide produced by Enterococcus mundtii ST4V isolated from soya beans. Int J Antimicrob Agents 25:508–513

Wachsman MB, Castilla V, De Ruiz Holgado AP, de Torres RA, Sesma F, Coto CE (2003) Enterocin CRL35 inhibits late stages of HSV-1 and HSV-2 replication in vitro. Antivir Res 58:17–24

Emiliano S, Lucila S, Fernando S (2007) Short peptides derived from the NH2-terminus of subclass IIa bacteriocin enterocin CRL35 show antimicrobial activity. J Antimicrob Chemother 59:1102–1108

Ishibashi N, Himeno K, Fujita K, Masuda Y, Perez RH, Zendo T, Wilaipun P, Leelawatcharamas V, Nakayama J, Sonomoto K (2012) Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish. Biosci Biotechnol Biochem 76:947–953

Férir G, Petrova M, Andrei G, Huskens D, Hoorelbeke B (2013) The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. PLoS One 8:e64010

Serkedjieva J, Danova S, Ivanova I (2000) Antiinfluenza virus activity of a bacteriocin produced by Lactobacillus delbrueckii. Appl Biochem Biotechnol 88:122–129

Lehtoranta L, Pitkäranta A, Korpela R (2014) Probiotics in respiratory virus infections. Eur J Clin Microbiol Infect Dis. doi: 10.1007/s10096-014-2086-y

Guillemard E, Tondu F, Lacoin F, Schrezenmeir J (2010) Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr 103:58–68

Maeda N, Nakamura R, Hirose Y, Murosaki S, Yamamoto Y, Kase T, Yoshikai Y (2009) Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. Int Immunopharmacol 9:1122–1125

Boge T, Remigy M, Vaudaine S, Tanguy J, Bourdet-Sicard R, van der Werf S (2009) A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 27:5677–5684

Olivares M, Diaz-Ropero MP, Sierra S, Lara-Villoslada F, Fonolla J, Navas M, Rodriguez JM, Xaus J (2007) Oral intake of Lactobacillus fermentum CECT5716 enhances the effects of influenza vaccination. Nutrition 23:254–260

de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K, Schrezenmeir J (2006) Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine 24:6670–6674

Rautava S, Salminen S, Isolauri E (2009) Specific probiotics in reducing the risk of acute infections in infancy a randomised, double-blind, placebo-controlled study. Br J Nutr 101:1722–1726

Leyer GJ, Li S, Mubasher ME, Reifer C, Ouwehand AC (2009) Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics 124:e172–e179

Chiba E, Tomosada Y, Guadalupe MVP, Salva S (2013) Immunobiotic Lactobacillus rhamnosus improves resistance of infant mice against respiratory syncytial virus infection. Int Immunopharmacol 17:373–382

Salva S, Nuñez M, Villena J, Ramón A, Font G, Alvarez S (2011) Development of a fermented goats’ milk containing Lactobacillus rhamnosus: in vivo study of health benefits. J Sci Food Agric 91:2355–2362

Clancy R (2003) Immunobiotics and the probiotic evolution. FEMS Immunol Med Microbiol 38:9–12

Yasui H, Kiyoshima J, Hori T (2004) Reduction of influenza virus titer and protection against influenza virus infection in infant mice fed Lactobacillus casei Shirota. Clin Diagn Lab Immunol 11:675–679

Kiso M, Takano R, Sakabe S, Katsura K, Shinya K, Uraki R (2013) Protective efficacy of orally administered, heat-killed Lactobacillus pentosus b240 against influenza A virus. Sci Rep 3:1563

Fong TT, Lipp EK (2005) Enteric viruses of humans and animals in aquatic environments: health risks, detection, and potential water quality assessment tools. Microbiol Mol Biol Rev 69:357–371

Farthing MJG (1989) Viruses and the gut. Smith Kline & French, Welwyn Garden City

Kocwa-Haluch R (2001) Waterborne enteroviruses as a hazard for human health. Pol J Environ Stud 10:485–487

Maragkoudakis PA, Chingwaru W, Gradisnik L, Tsakalidou E, Cencic A (2010) Lactic acid bacteria efficiently protect human and animal intestinal epithelial and immune cells from enteric virus infection. Int J Food Microbiol 141:S91–S97

Agarwal KN, Bhasin SK (2002) Feasibility studies to control acute diarrhea in children by feeding fermented milk preparations Actimel and Indian Dahi. Eur J Clin Nutr 56:S56–S59

Szajewska H, Mrukowicz JZ (2001) Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr 33:S17–S25

Sarker SA, Sultana S, Fuchs GJ, Alam NH, Azim T, Brussow H, Hammarstrom L (2005) Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh. Pediatrics 116:e221–e228

Cencic A, Chingwaru W (2010) The role of functional foods, Nutraceuticals, and food supplements in intestinal health. Nutrients 2:611–625

Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y (2004) Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104:3249–3256

UNAIDS, report on the global HIV/AIDS Epidemic 2000_: Executive Summary, UNAIDS, Genova Switzerland

Karim QA, Karim SSA, Frohlich JA et al (2010) Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 329:1168–1174

Rubab Z, Baig S, Siddiqui A, Nayeem A, Salman S, Qidwai A, Mallick R, Qidwai S (2013) Human papilloma virus—role in precancerous and cancerous oral lesions of tobacco chewers. J Pak Med Assoc 63:10

Cha MK, Lee DK, An HM, Lee SW, Shin SH, Kwon JH, Kim KJ, Ha NJ (2012) Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16. BMC Med 10:72

Khania S, Motamedifara M, Golmoghaddam H, Hosseinic HM, Hashemizadeha Z (2012) In vitro study of the effect of a probiotic bacterium Lactobacillus rhamnosus against herpes simplex virus type 1. Braz J Infect Dis 16:129–135

Jaïdane H, Hober D (2008) Role of coxsackievirus B4 in the pathogenesis of type 1 diabetes. Diabetes Metab 34:537–548

Hober D, Sauter P (2010) Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nat Rev Endocrinol 6:279–289

Qureshi TA, Mirbahar KB, Samo MU, Soomro NM, Solangi AA, Memon A (2006) Clinical study of experimentally induced anaphylactic shock in goats. Int J Pharmacol 2:357–361

Férir G, Petrova MI, Andrei G, Huskens D, Hoorelbeke B, Snoeck R, Vanderleyden J, Balzarini J, Bartoschek S, Brönstrup M, Süssmuth RD, Schols D (2013) The lantibiotic peptide labyrinthopeptin A1 demonstrates broad anti-HIV and anti-HSV activity with potential for microbicidal applications. PLoS One 8:e64010

Torres N, Sutyak N, Xu S, Li J, Huang Q, Sinko P (2013) Safety, formulation, and in vitro antiviral activity of the antimicrobial peptide subtilosin against herpes simplex virus type 1. Probiotics Antimicrob Proteins 5:26–35